Analyzing Resistance to RAS Inhibitors to Improve Therapeutic Design for Achieving Greater Durability of Responses
- Showcasing comprehensive profiling of resistance mechanisms which arise from RAS inhibitor treatment
- Generating resistance cell lines to identify acquired resistance mechanisms to KRAS inhibitors
- Evaluating molecular consequences and resistance mechanisms of direct KRAS Q61H-selective inhibitors